Nitration of unsaturated fatty acids such as linoleate by NO-derived reactive species forms novel derivatives (including nitrolinoleate [LNO 2 ]) that can stimulate smooth muscle relaxation and block platelet activation by either NO/cGMP or cAMP-dependent mechanisms. Here, LNO 2 was observed to inhibit human neutrophil function. LNO 2 , but not linoleic acid or the nitrated amino acid 3-nitrotyrosine, dose-dependently (0.2 to 1 mol/L) inhibited superoxide (O 2 ·Ϫ ) generation, Ca 2ϩ influx, elastase release, and CD11b expression in response to either phorbol 12-myristate 13-acetate or N-formyl-Met-Leu-Phe. LNO 2 did not elevate cGMP, and inhibition of guanylate cyclase by 1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one did not restore neutrophil responses, ruling out a role for NO. In contrast, LNO 2 caused elevations in intracellular cAMP in the presence and absence of phosphodiesterase inhibition, suggesting activation of adenylate cyclase. Compared with phorbol 12-myristate 13-acetate-activated neutrophils, N-formyl-Met-Leu-Phe-activated neutrophils were more susceptible to the inhibitory effects of LNO 2 , indicating that LNO 2 may inhibit signaling both upstream and downstream of protein kinase C. These data suggest novel signaling actions for LNO 2 in mediating its potent inhibitory actions. Thus, nitration of lipids by NO-derived reactive species yields products with antiinflammatory properties, revealing a novel mechanism by which NO-derived nitrated biomolecules can influence the progression of vascular disease. (Circ Res. 2002;91:375-381.) 
N itric oxide is a free radical signaling mediator generated by the healthy endothelium to maintain vascular homeostasis through the regulation of blood pressure and leukocyte-platelet activation. When generated at elevated levels during inflammation by inducible NO synthase in a variety of cell types, NO is readily transformed into potent nitrating and nitrosating species, including peroxynitrite (ONOO Ϫ ), nitrogen dioxide (NO 2 ), and nitrous acid (HONO). These species can react with unsaturated lipids, forming both oxidized and nitrated products, including nitro, nitrito, and nitroepoxy derivatives. [1] [2] [3] [4] Several recent studies have demonstrated in vivo generation of nitrated lipids. For example, bovine cardiac muscle and human plasma contain species with chromatographic and mass spectral properties identical to those of nitrated arachidonate and linoleate, whereas plasma from rats exposed to liver ischemia/reperfusion contains nitrolinoleate 5,6 (D.G. Lim, B.A. Freeman, unpublished data, 2002). Treatment of LDL with nitrating/nitrosating and oxidizing species that are generated during myeloperoxidase oxidation of nitrite (NO 2 Ϫ ) causes its modification to a form recognized by the macrophage scavenger receptor CD36. 7, 8 Also, macrophage uptake of LDL treated with nitrating/ nitrosating species stimulates cholesteryl ester synthesis, intracellular cholesterol and cholesteryl ester accumulation, and foam cell formation. 9, 10 Finally, synthetic nitrated lipids derived from either arachidonate or linoleate inhibit multiple indices of platelet activation and cause smooth muscle relaxation 5, 11 (D.G. Lim, B.A. Freeman, unpublished data, 2002). These observations raise the possibility that nitrated lipids could modulate atherogenesis and/or inflammation in vivo.
Activation of phagocytic leukocytes, including neutrophils, is a central feature of inflammatory disease. [12] [13] [14] [15] [16] For example, neutrophil rolling and adhesion to the endothelium are enhanced in apoE and double apoE/LDL receptor-knockout mice, whereas neutrophils from septic patients show alterations in integrin expression and O 2 ·Ϫ generation. [13] [14] [15] [16] Also, mice deficient in adhesion molecules or chemokines and their receptors show impaired immune responses and diminished atherosclerosis. 12, [17] [18] [19] Neutrophil function in vivo can be regulated through NO-and eicosanoid-dependent mechanisms. 20 -22 In this regard, nitrated unsaturated lipids formed by reaction with NO-derived reactive nitrogen species are of potential interest, inasmuch as they could influence neutrophil activation through either reactivity and may lead to the development of novel therapeutic strategies for inflammation.
A synthetic nitrated lipid, nitrolinoleate (LNO 2 ), which is structurally similar to that generated by ONOO Ϫ -or NO 2induced linoleate nitration, is reported in the present study to inhibit N-formyl-Met-Leu-Phe (fMLP)-and phorbol 12-myristate 13-acetate (PMA)-mediated activation of human neutrophils. 1 Superoxide generation, degranulation, and CD11b expression were inhibited at LNO 2 concentrations Ͻ1 mol/L and occurred in concert with attenuated elevations in intracellular Ca 2ϩ and increased intracellular cAMP. Compared with PMA-activated neutrophils, fMLP-activated neutrophils were more susceptible to LNO 2 inhibition, indicating that LNO 2 may inhibit signaling upstream and downstream of protein kinase C. In aggregate, these data reveal that nitrated lipids potently inhibit leukocyte activation and demonstrate novel mechanisms by which NO-derived nitrated biomolecules may attenuate tissue inflammatory responses.
Materials and Methods

Materials
Lymphoprep was obtained from Nycomed Pharma. Unless otherwise stated, all other reagents were obtained from Sigma-Aldrich Ltd.
Synthesis and Purification of LNO 2
The synthesis and purification of LNO 2 have recently been described elsewhere and have been adapted from previous strategies for the synthesis of conjugated nitroalkenes via nitroselenylation of alkenes. 11, 23, 24 Briefly, linoleic acid (LA), HgCl 2 , PheSeBr, and AgNO 2 (1.0:1.3:1.0:1.0 [mol/mol]) were combined in THF-acetonitrile (1:1 [vol/vol]), with a final concentration of 0.15 mol/L LA. The mixture was degassed and stirred at 25°C in the dark for 1.5 hours, the supernatant was recovered, and solvent was removed in vacuo. Lipid was solvated again in THF, and a 10-fold molar excess of H 2 O 2 was added to the lipid mixture after cooling to 0°C. After 20 minutes, the solution was warmed to Ϸ25°C until gas evolution was noted. The solution was cooled to 10°C, followed by stirring at Ϸ25°C for 30 minutes. Lipids were extracted and then chromatographed on a silica gel column (250 to 400 mesh) using a hexane-CHCl 3 step gradient (5% increments from 0% to 30% CHCl 3 ), with LNO 2 predominantly eluting in the 20% to 30% CHCl 3 fraction, as determined by negative-ion-mode mass spectroscopic monitoring of fractions. Further purification was accomplished by high pressure liquid chromatography using 0.1% acetic acid in 50% to 90% CH 3 OH gradient on a 4.6ϫ250-m reverse-phase C18 column. LNO 2 yields were quantified by elemental analysis of nitrogen content after pyrolysis by chemiluminescent nitrogen detection (Antek Instruments), with caffeine used as a standard. After purification and quantification, LNO 2 was stored in CH 3 OH under inert gas at Ϫ80°C. For all cell experiments, appropriate controls using methanol were carried out to exclude solvent effects, and methanol concentrations were always Ͻ0.1%.
Neutrophil Isolation
Human neutrophils were isolated from 20 mL citrate anticoagulated whole blood as described. 25 Approval for blood donations from healthy volunteers was given by the Bro Taf Local Research Ethics Committee, and all donors gave written consent. Briefly, blood was mixed 1:1 with 0.8% trisodium citrate (wt/vol) and 2% dextran (wt/vol) in PBS (containing 137 mmol/L NaCl, 2.68 mmol/L KCl, 8.1 mmol/L Na 2 HPO 4 , and 1.47 mmol/L KH 2 PO 4 ) and allowed to sediment for 45 minutes at 20°C. After this procedure, the upper plasma layer was underlaid with ice-cold Lymphoprep (2:1 for plasma/Lymphoprep) and centrifuged (800g, 20 minutes, 4°C). The pellet was resuspended in ice-cold PBS and 0.4% trisodium citrate (wt/vol) and centrifuged (400g, 5 minutes). Contaminating erythrocytes were removed using 3 cycles of hypotonic lysis. Finally, cells were resuspended in a small volume of Krebs buffer (100 mmol/L NaCl, 50 mmol/L HEPES, 5 mmol/L KCl, 1 mmol/L MgCl 2 , 1 mmol/L NaH 2 PO 4 , 1 mmol/L CaCl 2 , 2 mmol/L D-glucose, and 5 U/mL heparin, pH 7.4), counted, and kept on ice.
Neutrophil Fractionation
For the preparation of subcellular fractions, neutrophils were purified as described above with the omission of the dextran sedimentation step. Neutrophils were treated with 2.5 mmol/L diisopropyl fluorophosphate for 10 minutes at 4°C, disrupted in relaxation buffer (100 mmol/L KCl, 3 mmol/L NaCl, 3.5 mmol/L MgCl 2 , 1 mmol/L ATP, 1.25 mmol/L EGTA, and 10 mmol/L PIPES, pH 7.3) by N 2 cavitation, and fractionated on a discontinuous Percoll gradient. 26, 27 This method produces cytosolic and plasma membrane fractions whose final concentrations were adjusted to 9ϫ10 7 and 1.25ϫ10 9 cell equivalents per milliliter, respectively. Fractions were stored at Ϫ80°C for up to 1 year without loss of activity.
Superoxide Generation
Neutrophil O 2 ·Ϫ generation was determined using superoxide dismutase-sensitive cytochrome c reduction. 28 Cells (10 6 ) were added to 2 mL Krebs buffer containing 50 mol/L ferricytochrome c, with stirring, at 37°C. Cells were activated using either 1 mol/L fMLP or 1 g/mL PMA, and absorbance was monitored at 550 nm (⑀ 21.1 cm Ϫ1 · mmol/L for ferrocytochrome c). To confirm O 2 ·Ϫ generation, superoxide dismutase (300 U/mL) was added in control experiments. Where used, the soluble guanylate cyclase (sGC) inhibitor 1H- [1, 2, 4] oxadiazole[4,3-a]quinoxalin-1-one (ODQ, 4 mol/L) was preincubated with neutrophils 20 minutes before the assay. Superoxide generation by isolated neutrophil membranes was measured after the addition of 160 mol/L NADPH to 0.75 mL relaxation buffer containing 5.4ϫ10 6 cell equivalents of membrane extract per milliliter, 1.5ϫ10 7 cell equivalents of cytosol per milliliter, 10 mol/L GTP-␥-S, 100 mol/L SDS, and 50 mol/L cytochrome c. To facilitate the assembly of NADPH oxidase components, all constituents (excluding NADPH) were preincubated at 25°for 5 minutes before the addition of NADPH. LNO 2 (10 mol/L) was added in ethanol (final concentration 0.1%) either during NADPH oxidase assembly or immediately before NADPH addition.
Measurement of Neutrophil [Ca 2؉ ic ]
Neutrophils prepared as described were incubated at 10 7 /mL with 5 mol/L fura 2-AM (Molecular Probes) in Ca 2ϩ -free Krebs buffer at 37°C for 20 minutes. Then, cells were centrifuged at 400g for 10 minutes, resuspended in Ca 2ϩ -free Krebs buffer at 10 7 /mL, kept on ice, and studied within 90 minutes. Fluorescence of neutrophils (10 6 /mL) was measured using a Perkin-Elmer LS 50B fluorescence spectrophotometer at 37°C with stirring. Excitation wavelengths were 340 and 380 nm, with an emission wavelength of 509 nm. Corrections were applied for autofluorescence (unloaded neutrophils), and calibrations were performed by adding 1 mol/L ionomycin, 1 mmol/L CaCl 2 
Determination of CD11b Expression
Expression of CD11b (␣M integrin, MAC-1) was determined by flow cytometry. 29 Briefly, isolated neutrophils (2ϫ10 6 /mL) were incubated with and without LNO 2 (3.6 mol/L) for 2 minutes at 37°C. After this procedure, fMLP (1 mol/L) was added, and samples were incubated for a further 5 minutes at 37°C. Anti-human CD11b-FITC (10 L, Serotec) or isotype control was then added, and samples were incubated for 30 minutes at 4°C. Finally, cells were washed once with ice-cold PBS and then resuspended in 0.1% paraformaldehyde-PBS until flow cytometry analysis. Neutrophils were analyzed on a FACScan flow cytometer (Becton Dickinson) and identified by forward and side scatter and FITC.
Determination of Neutrophil Degranulation by Elastase Release
Degranulation of azurophilic granules was determined by elastase release. 30 Briefly, isolated neutrophils were resuspended at 2ϫ10 6 /mL Krebs buffer containing 1 g/mL cytochalasin B and 40 mol/L MeO-Suc-Ala-Ala-Pro-Val-MCA at 37°C with stirring. After 5 minutes, 1 mol/L fMLP was added, and fluorescence was monitored (excitation wavelength 380 nm, emission wavelength 460 nm). In some experiments, 3 mol/L LNO 2 was added 2 minutes before fMLP.
Determination of cAMP and cGMP
For cAMP, neutrophils (2ϫ10 6 /mL) in Krebs buffer were prewarmed to 37°C for 3 minutes. Then, 3.6 mol/L LNO 2 with or without 1 mmol/L 3-isobutyl-1-methylxanthine (IBMX) was added, and samples were incubated for 1 minute at 37°C. Then, proteins were precipitated using ice-cold 6% trichloroacetic acid, which was subsequently removed by washing samples several times with water-saturated diethyl ether. For cGMP, neutrophils (4ϫ10 6 /mL) in Krebs buffer were incubated for 5 minutes at 37°C with or without 1 mmol/L IBMX, 10 mol/L LNO 2 , or 10 mol/L 2(N,Ndiethylamino)-diazenolate-2-oxide (DEANONOate). Then, proteins were precipitated using ice-cold 66% ethanol. Cyclic nucleotides were determined by radioimmunoassay (Biotrak, Amersham).
Results
LNO 2 Inhibits fMLP-or PMA-Induced O 2
·؊
Generation by Intact Neutrophils but Not by Reconstituted NADPH Oxidase
Addition of LNO 2 (0.5 to 5 mol/L) to stirred neutrophils in suspension did not stimulate O 2 ·Ϫ generation (not shown). However, LNO 2 added to neutrophils 2 minutes before agonist activation using either 1 mol/L fMLP or 1 g/mL PMA led to concentration-dependent inhibition of O 2 ·Ϫ generation ( Figures 1A, 1B, and 1D) . In contrast, similar concentrations of the parent fatty acid, LA, or the nitrated amino acid, 3-nitrotyrosine (3-NT), were without effect ( Figure 1C ). This indicates that inhibition of neutrophil activation was specific to LNO 2 and was not a feature of all unsaturated lipids or nitro-containing compounds. Neutrophil membranes were isolated and assayed for O 2 ·Ϫ generation in a reconstituted system after the addition of NADPH. Preincubation of neutrophil membranes during assembly with 10 mol/L LNO 2 slightly suppressed O 2 ·Ϫ generation rates, although this was not significant (Figure 2A) . Also, the addition of LNO 2 to the enzyme that had been allowed to preassemble in vitro had no effect on O 2 ·Ϫ generation. These data indicate that LNO 2 does not inhibit O 2 ·Ϫ generation through a direct effect on NADPH oxidase assembly or turnover.
cGMP Synthesis Is Not Involved in Inhibition of Neutrophil O 2 ·؊ Generation by LNO 2
To examine whether NO was involved in the inhibitory effects of LNO 2 , the sGC inhibitor ODQ was added. This did not restore neutrophil O 2 ·Ϫ generation in response to fMLP ( Figure 2B ). Separately, cellular cGMP levels were found to be unchanged after a 5-minute incubation with LNO 2 in contrast to DEANONOate, which was used as a positive control ( Figure 2C) . These data rule out a role for NO activation of sGC in the inhibitory actions of LNO 2 .
Effect of LNO 2 on CD11b Exposure in Response to fMLP
Basal neutrophil expression of CD11b, as evidenced by the difference in fluorescence between cells stained with either anti-CD11b antibody or isotype control, was not affected by LNO 2 (Figure 3 ). fMLP activation of neutrophils induced a further significant increase in CD11b expression ( Figures 3A  and 3C ), which was fully inhibited by preincubation of cells with 3 mol/L LNO 2 (Figures 3B and 3C ). This indicates that LNO 2 can inhibit neutrophil functions associated with adhesion.
LNO 2 Attenuates fMLP-Induced Degranulation
Pretreatment of neutrophils with 3 mol/L LNO 2 blocked fMLP-induced azurophilic degranulation, as measured by elastase release, whereas the addition of LNO 2 to unstimulated cells had no effect ( Figures 4A and 4B ). This indicates that neutrophil functions associated with tissue damage and bacteriolysis can be attenuated by LNO 2 .
LNO 2 Attenuates Ca 2؉ Mobilization in Response to fMLP
To examine the mechanisms of LNO 2 inhibition of neutrophil activation, Ca 2ϩ mobilization in response to fMLP was monitored by fura 2-AM fluorescence. On the addition of 1 mol/L fMLP to Ca 2ϩ -containing samples, a characteristic increase in [Ca 2ϩ ic ] was observed ( Figure 5A ). Preincubation of neutrophils with 3 mol/L LNO 2 significantly attenuated fMLP-induced Ca 2ϩ mobilization and accelerated the subsequent rate of Ca 2ϩ removal, whereas the addition of LNO 2 to unstimulated cells had no effect ( Figure 5 ). In the absence of external Ca 2ϩ , LNO 2 did not alter the kinetics of Ca 2ϩ mobilization ( Figure 6 ), indicating that LNO 2 primarily exerted an effect on external Ca 2ϩ fluxes in neutrophils.
LNO 2 Elevates cAMP in Neutrophils
LNO 2 inhibits platelet activation via a cAMP-dependent pathway. 11 To determine whether similar mechanisms are operative in neutrophils, cAMP was determined after incubation with LNO 2 . After a 1-minute incubation with 3.6 mol/L LNO 2 , a 40% increase in cAMP was observed (Figure 7) . However, in the presence of the phosphodiesterase inhibitor IBMX, LNO 2 caused a 3-fold elevation in neutrophil cAMP levels. This indicates that LNO 2 elevates cAMP synthesis through the activation of adenylate cyclase in neutrophils. 
Discussion
Nitrated lipid has recently been found in human plasma, bovine cardiac tissue, and plasma from a rat model of liver ischemia/reperfusion, with extensive nitration and oxidation of biomolecules also occurring in human atheroma 5,6,31 (D.G. Lim, B.A. Freeman, unpublished data, 2002). Nitrated lipids, including LNO 2 , possess vascular protective properties through the inhibition of platelet activation and promotion of smooth muscle relaxation 5,11 (D.G. Lim, B.A. Freeman, unpublished data, 2002). In the present study, the influence of LNO 2 on human neutrophil functional responses was examined to characterize their bioactivity toward proinflammatory leukocytes, which are central to the pathogenesis of atherosclerosis. LNO 2 (0.1 to 1 mol/L) inhibited neutrophil activation in response to PMA or fMLP, as indicated by the inhibition of O 2 ·Ϫ generation, Ca 2ϩ mobilization, azurophilic degranulation, and CD11b expression. This reveals that lipid nitration results in the formation of an antiinflammatory and vascular-protective product that potently attenuates multiple leukocyte functions.
Neutrophil cytotoxicity requires efficient degranulation to release proteases and other degradative enzymes. In the present study, LNO 2 effectively blocked fMLP-induced azurophilic degranulation, indicating that events associated with bacterial killing and cell damage are attenuated by nitrated lipids (Figure 4) . The cell surface glycoprotein, CD11b (␣M integrin, MAC-1), is expressed as a heterodimer with CD18 (C receptor type 3) on the surface of leukocytes in response to activating agonists such as fMLP and is involved in adhesion to endothelial cells and in transendothelial migration to inflammatory sites. 32, 33 Recruitment of leukocytes to the arterial wall is an important event in atherogenesis and plaque rupture. 12, [17] [18] [19] 32, 33 This is mediated via leukocyte integrin receptors, including CD11b, and is modulated by a variety of both endothelium-and leukocyte-derived lipid oxidation products and free radicals, including O 2 ·Ϫ , NO, prostaglandins, and isoprostanes. 34 -42 Inhibition of fMLPinduced CD11b expression by LNO 2 indicates that nitrated lipids also modulate leukocyte responses associated with the development of vascular disease (Figure 3 ).
Stimulation of neutrophils by fMLP or PMA causes translocation of at least 3 different cytosolic proteins (p67-phox, p47-phox, and p21-rac1) to the membrane, where they interact with 2 membrane-bound proteins (gp91-phox and p22-phox) to form the active O 2 ·Ϫ -generating NADPH oxidase complex. To determine whether LNO 2 exerted its inhibitory actions directly on NADPH oxidase or prevented complex assembly, neutrophil membranes were isolated and assayed for O 2 ·Ϫ generation in a reconstitution system after the addition of NADPH. The lack of inhibition by LNO 2 in this assay indicates that LNO 2 exerts its inhibitory effects upstream of NADPH oxidase (Figure 2A ). There are at least 2 potential mechanisms by which nitrated lipids may exert cell signaling. The inhibition of platelet activation by LNO 2 requires cAMP synthesis, whereas stimulation of smooth muscle relaxation by LNO 2 or nitrated arachidonate involves cellular metabolism of the nitro functional group to NO 5,11 (D.G. Lim, B.A. Freeman, unpublished data, 2002). An elevation in either cGMP or cAMP can inhibit neutrophil function and is consistent with the observed effects of LNO 2 on agonist-induced Ca 2ϩ elevations. 34 -39 However, cGMP was ruled out because (1) elevations in response to LNO 2 did not occur and (2) inhibition of sGC did not restore neutrophil activation (Figure 2 ). In contrast, LNO 2 increased intracellular cAMP, in the presence and absence of IBMX, suggesting an involvement of this metabolite ( Figure  7) . Previous studies have shown that cAMP inhibits fMLPbut not PMA-stimulated neutrophil O 2 ·Ϫ generation. This indicates that cAMP acts upstream of protein kinase C. 40 Therefore, inhibition of PMA-stimulated O 2 ·Ϫ generation by LNO 2 suggests an additional cAMP-independent mechanism of action. In support, fMLP-activated neutrophils were considerably more susceptible to the inhibitory effects of LNO 2 than when they were stimulated with PMA ( Figures 1B and  1D) .
This preparation of LNO 2 is a mixture of 4 positional isomers identified using nuclear magnetic resonance and IR spectroscopy (D.G. Lim, B.A. Freeman, unpublished data, 2002), and this preparation was used because it can be synthesized with a relatively high yield and purity. Levels of nitrated lipid in vivo are too low to allow purification of amounts sufficient for biological studies. Similarly, nitration of linoleate through oxidant pathways (eg, ONOO Ϫ and NO 2 ) in vivo will also form a mixture of LNO 2 isomers. Metabolism to release NO by smooth muscle cells is unlikely to be isomer specific; however, activation of adenylate cyclase through receptor-dependent pathways may be more effective with Ն1 specific isomer.
Data from the present study and others indicate that lipid nitration results in the formation of compounds that can signal through either NO-or cAMP-dependent pathways, with the biological mechanism of action being highly cell type dependent 5, 11 (D.G. Lim, B.A. Freeman, unpublished data, 2002). For example, LNO 2 mediates smooth muscle relaxation through exclusively cGMP-dependent mechanisms, whereas in platelets and neutrophils, there is no role for NO, with its biological effects being at least partly cAMP dependent 11 (D.G. Lim, B.A. Freeman, unpublished data, 2002, and data in the present study). The reasons for this may involve (1) different cellular rates of metabolism of LNO 2 to NO and/or (2) differences in the expression of eicosanoid receptors that activate adenylate cyclase.
In summary, the present study shows that LNO 2 potently blocks multiple neutrophil proinflammatory responses, including degranulation, O 2 ·Ϫ generation, and integrin expression. This indicates that nitrated lipids will attenuate leukocyte migration and subsequent activation in atherosclerotic lesions, demonstrating a further vascular protective property of these compounds in addition to antiplatelet and vasorelaxing effects 5, 11 . LNO 2 elevates cAMP in neutrophils. Neutrophils (2ϫ10 6 /mL) in Krebs buffer were prewarmed to 37°C for 3 minutes. LNO 2 (3.6 mol/L) with/without 1 mmol/L IBMX was then added, and samples were incubated for 1 minute at 37°C. cAMP was determined as described in Materials and Methods using a commercial radioimmunoassay kit. For all data, values are meanϮSD (nϭ3), and all experiments were repeated at least 3 times on different donors. *PϽ0.005 vs control or IBMX after independent t test.
